offline
Pfizer (PFE) Q2 Earnings Beat, View Up on COVID-19 Vaccine
Pfizer, Inc. PFE reported second-quarter 2021 adjusted earnings per share of $1.07, which comprehensively beat the Zacks Consensus Estimate of 97 cents. Earnings rose 73% year over year.
Revenues came in at $18.98 billion, which beat the Zacks Consensus Estimate of $17.54 billion. Sales rose 92% from the year-ago quarter on a reported basis and 86% on an operational basis, mainly driven by sales of Pfizer and partner BioNTech’s BNTX COVID-19 vaccine, BNT162b2. The vaccine contributed $7.8 billion in global sales in the quarter. Excluding revenues from BNT162b2, sales grew 10% operationally.
...
https://finance.yahoo.com/news/pfizer-pf...01478.html
![[Bild: PFEd083370224i.png]](https://finviz.com/publish/072921/PFEd083370224i.png)
Pfizer, Inc. PFE reported second-quarter 2021 adjusted earnings per share of $1.07, which comprehensively beat the Zacks Consensus Estimate of 97 cents. Earnings rose 73% year over year.
Revenues came in at $18.98 billion, which beat the Zacks Consensus Estimate of $17.54 billion. Sales rose 92% from the year-ago quarter on a reported basis and 86% on an operational basis, mainly driven by sales of Pfizer and partner BioNTech’s BNTX COVID-19 vaccine, BNT162b2. The vaccine contributed $7.8 billion in global sales in the quarter. Excluding revenues from BNT162b2, sales grew 10% operationally.
...
https://finance.yahoo.com/news/pfizer-pf...01478.html
__________________
